📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Genetically proxied PCSK9 inhibition provides indication of lower prostate cancer risk: a Mendelian randomization study (2022)

First Author: Fang S

Attributed to: Data mining epidemiological relationships: integration of causal analysis with published evidence funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2022.04.18.22274003

Publication URI: http://dx.doi.org/10.1101/2022.04.18.22274003

Type: Preprint